Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane in sudden death.

A K Myers, P W Ramwell

    Advances in Prostaglandin, Thromboxane, and Leukotriene Research
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Thromboxane plays a key role in thrombotic sudden death. Blocking thromboxane receptors or using calcium-channel blockers like nifedipine can prevent this cardiovascular event.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Perceptions of Insulin Pen Use and Technique in Black and Hispanic/Latino Patients with Type 2 Diabetes: a Qualitative Study.

    Journal of racial and ethnic health disparities·2020
    Same author

    Maternal attitudes towards prenatal diagnosis of idiopathic clubfoot.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
    Same author

    Clinical and molecular findings in IPEX syndrome.

    Archives of disease in childhood·2005
    Same author

    Choanal atresia - a recurrent feature of foetal carbimazole syndrome.

    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2005
    Same author

    Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.

    Alcoholism, clinical and experimental research·2000
    Same author

    Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1999

    Area of Science:

    • Cardiovascular Research
    • Pharmacology
    • Thrombosis Studies

    Background:

    • Thromboxane is implicated in cardiovascular disease and thrombotic sudden death.
    • Experimental models demonstrate thromboxane's role as a mediator in sudden death.
    • Factors like gender, species, and endocrine status influence susceptibility to experimental sudden death.

    Purpose of the Study:

    • To investigate the role of thromboxane in thrombotic sudden death models.
    • To evaluate the efficacy of agents targeting thromboxane generation and receptor activation.
    • To assess the in vivo antiplatelet effects of calcium-channel blockers in preventing thrombosis.

    Main Methods:

    • Utilized arachidonic acid-induced sudden death models.
    • Employed thromboxane mimetics to induce sudden death.

    Related Experiment Videos

  • Administered cyclooxygenase inhibitors, thromboxane synthetase inhibitors, and thromboxane receptor antagonists.
  • Tested calcium-channel blockers (nifedipine, nisoldipine, verapamil) in vivo.

    • Main Results:

    • Inhibition of thromboxane generation or receptor blockade prevented arachidonic acid-induced sudden death.
    • Thromboxane mimetics induced sudden death, with only receptor antagonists showing protective effects.
    • Dihydropyridine calcium-channel blockers (nifedipine, nisoldipine) demonstrated protective effects against thrombosis.
    • Nifedipine pretreatment prevented sudden death induced by various thrombotic challenges.

    Conclusions:

    • Thromboxane receptor antagonism is effective in preventing thromboxane mimetic-induced sudden death.
    • Thrombotic sudden death models are valuable for in vivo evaluation of antithrombotic agents.
    • Dihydropyridine calcium-channel blockers show promise as antithrombotic agents in vivo.